IP Verse

Antitumor Agent And Antitumor Effect Enhancer

Patent No. EP3042669 (titled "Antitumor Agent And Antitumor Effect Enhancer") was filed by Taiho Pharmaceutical on Sep 5, 2014. The application was issued on Mar 8, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GENERICS UKDec 7, 2023TER MEER STEINMEISTER & PARTNER
CAMULONNov 29, 2023REDDIE & GROSE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3042669

TAIHO PHARMACEUTICAL
Application Number
EP14842538A
Filing Date
Sep 5, 2014
Status
Granted And Under Opposition
Feb 3, 2023
Publication Date
Mar 8, 2023
External Links
Slate, EP3042669B1, Google Patents